137
. For each of these, the region in LD with the most 146 significant respective marker in the breed-average weight imputed GWAS contained the known or 147 putative causal variant (S1 Fig.) . While the putative causal variants weren't always the highest 148 associated variant at a locus, they generally had P-values within two orders of magnitude of the 149 most associated marker (S1 Fig.) , confirming that the imputation panel performs well for the 150 weight GWAS. 154 5 for breed-average weight GWAS) did not reach significance, but with the imputed data we saw a 155 significant association signal (P = 1.6×10 -12 for breed-average weight GWAS), and the causal 156 variant was the 6 th most associated SNP (r 2 = 0.73 between causal and associated SNP) (S1 Fig.   157 a). The STC2 and GHR (4:67,040,898) putative causal variants were the most significant variants 158 at those loci in the imputed GWAS (S1 Fig. b ,c). Note that there are two putative causal variants 159 for GHR (17), both in exon 5, but only one passed our 5% MAF filter. Similarly, the HMGA2 160 causal variant was in high LD (r 2 =0.91) with the most significant marker at this locus in the 161 imputed GWAS (S1 Fig. e ).
162
For IGF1, SNP5 (BICF2P971192, 15:41,221,438) , which is in LD with the SINE element (18), was 163 the most significant association in the array GWAS. In the imputed GWAS, SNP5 was the 2 nd 164 most associated SNP and the SNP that tags the SINE element (15:41,220,982) was the 4 th most 165 associated SNP, and these SNPs were nearly in complete LD with the most significant marker in 166 the GWAS (r 2 =0.98 and 0.97 respectively) (S1 Fig. f ). The IGSF1 missense mutation (26) was in 167 high LD with the most significant association in the imputed GWAS (r 2 =0.97) (S1 Fig. i ). Note that 168 there is a second variant in IGSF1 -an in-frame deletion -that has also been identified (26 
182
The most significant SNP at CFA9:12 is located about 200kb upstream of the gene growth 183 hormone 1 (GH1) ( Fig. 3a) , which is expressed in the pituitary and has been associated with body 184 size in humans and cattle (27) (28) (29) . The non-reference, derived indel that was the most highly 185 associated in our imputed GWAS is found at high frequency in two small breeds Papillon and 
192
The second novel body size QTL is at CFA26:7 ( Fig. 3b 
203
With the imputation panel, we saw a refinement in several QTL regions -for example, the 204 chromosome 3 association near the genes LCORL and ANAPC13, both of which have previously 205 been associated with body size (5, 15, 29, 30, 32) . Using imputed data, this QTL had a more 206 significant and defined association, compared to the CanineHD array data alone (S2 Fig. a) . The
207
QTL interval is about 65kb and 60kb upstream of the genes LCORL and ANAPC13 respectively,
208
suggesting the causal variant is likely regulatory. Another example is the recently identified body 209 size QTL at CFA7:30 Mb, near the gene TBX19 (8). Here the imputed GWAS results showed a 210 narrower QTL interval of greater significance when compared to the array GWAS (S2 Fig. b ). This 211 region overlaps TBX19 but we did not observe any coding loci in our snpEff annotated variant 212 files that are in LD with the most associated SNP.
214
Allelic heterogeneity
215
In order to reduce phenotypic noise, again we included the four most-associated QTLs (CFA10:8,
216
CFA15:41, CFA3:91, CFA7:43) as covariates in the GWAS (hereafter referred to as "top 4 217 covariates"), and then implemented a region-specific stepwise approach, including further 218 associated SNPs in the region as covariates, until no significant association signal remained. For 219 breed-average body weight, when we regressed out the most significant association for a QTL,
220
we expected the association signal to disappear, as seen with the SMAD2 QTL ( Fig. 4a ).
221
Our results showed two QTLs (CFA3:91, CFA10:8) that retain significant association signal after 222 regressing out the most associated locus in the respective region ( Fig. 4b,c ). For both CFA3 and 223 CFA10, the data suggest there may be two independent significant associations in these regions.
224
In the CFA3 region, the initial association signal peak looked regulatory while the residual signal 225 is located in the genes ANAPC13 and LCORL. 
230
other QTLs (CFA4:67 and CFA15:41) showed evidence of residual signal but these did not reach 231 significance (P = 2.9×10 -7 and 2.9×10 -8 , respectively).
232
This residual signal suggested allelic heterogeneity in these regions but could also be due to 233 imperfect tagging in the imputed dataset. As a follow-up analysis, for each of these two QTLs
234
(CFA3:91 and CFA10:8), we took the most significant SNP from the top 4 covariates GWAS. We 235 used that significant SNP as a covariate in a GWAS to see if we were able to recover the most 236 significant SNP from the initial GWAS with no covariates. For both CFA3 and CFA10, we did 237 recover the initial associated SNP, suggesting that these are real associations and not midway 238 between two imperfectly tagged SNPs.
240
Blood phenotypes
241
Using our imputed panel for GWAS on blood phenotypes revealed several novel associations.
242
For example, we saw significant associations with the phenotypes of albumin and calcium levels 243 in peripheral blood (P = 4.5×10 -10 and 5.9×10 -9 respectively), neither of which were previously 244 identified in the array GWAS (33) (S3 Table) . We also identified a novel association with blood 245 glucose level and CFA1, located in the gene solute carrier family 22 member 1 (SLC22A1) and 246 about 30kb downstream of the insulin-like growth factor 2 receptor gene (CI-MPR/IGF2R) ( Fig.   247 5d). During gestation, IGF2R binds insulin-like growth factor 2 (IGF2), the presence of which 248 stimulates the uptake of glucose (34). The SNP was at highest frequency (>50%) in the Samoyed
249
and American Eskimo dog breeds.
250
Of the eight significant associations (using a threshold of P = 1.0×10 -8 ) we saw with the imputed 251 data, only two were not novel -alanine aminotransferase (ALT) and amylase -although both 252 increased in significance ( Fig. 5g, 5h ; S3 Table) . In addition to significant associations, we also 11 253 saw six associations that nearly meet our significance threshold, that is, P < 2.0×10 -8 , including 254 three that were not significant using the genotype data (S3 Table) .
256
Discussion:
257 Imputation increases GWAS power by including additional sites that are not well-tagged by any 258 single array marker, and has been successfully implemented in human studies, for example, low- 
267
With our imputation panel, we improved association mapping for previously studied phenotypes, 268 such as body size. Previous mapping studies of canine body size and other morphological traits 269 using CanineHD array data have identified many significant QTLs. This success is largely the 270 result of selection for body size during the formation of dog breeds, leading to selective sweeps 271 around large-effect loci that facilitated mapping efforts. Nevertheless, using the imputation panel,
272
we were able to identify two additional novel loci (at CFA9:12 and CFA26:7) that influence body 273 size although functional studies, which are beyond the scope of this research study, are required 274 to validate these two loci. Using imputation, we were also able to narrow intervals for previously 275 known associated QTLs, and find evidence of possible allelic heterogeneity at two loci.
276
Furthermore, imputation provides a more accurate analysis of the genetic architecture underlying 277 canine body size and, in turn, allows a more accurate prediction for body size in dogs.
278
Imputation is especially helpful in across-breed and/or mixed-breed study designs, where LD 279 breaks down very rapidly making it more difficult to identify associations. Increasing the number 280 and density of queried variants (as done by imputation) increases the chance that a variant will be 12 281 in LD with the causal variant, especially when compared to a within-breed study design. We used 282 our imputation panel for across-breed GWAS of blood phenotypes, resulting in several novel 283 associations and the narrowing of associated intervals when compared to array data alone.
284
Although costs of WGS are decreasing, it is still more cost-effective to use a panel of WGS 
292
Furthermore, human studies have shown that imputation accuracy increases with the size of the 293 reference panel (41, 42) .
294
In summary, using our canine imputation panel of 24 million variants results in an increase in 295 GWAS power, even for phenotypes that have multiple significant associations. The improvements 296 to canine GWAS, especially for complex phenotypes, will not only further the field of canine 297 genetics, but may also have beneficial implications for human medical genetics -especially for 298 complex diseases, such as cancer, for which the domestic dog is a good model organism (43).
300
Material and Methods:
301
Whole genome sequences
302
The 365 whole genome sequences include 210 breed dogs (from 76 breeds), 107 village dogs 303 (from 13 countries), and 28 wolves (S4 Table) . 88 of these were sequenced at the Cornell 304 University BRC Genomics Facility; others were sourced from public databases (S4 Table) 
312
Imputation panel
313
SHAPEIT v2.r790(49) was used to phase the genotype data from 6,112 dogs as previously 314 described (8) and then IMPUTE2 version 2.3.0 (50) was used to impute across these data.
315
Imputation was only performed on the autosomes and chromosome X, not on the Y chromosome 
331
Marker Datasets
332
For the genotype data, individuals were run on a semi-custom Illumina CanineHD array of 185k
333
SNPs, and quality control steps were performed as previously described (8 
340
For the imputed panel, GWAS was performed for each canine chromosome (CFA1-39) 341 separately. The kinship matrix calculated using the array data in GEMMA was also used in the 342 imputed GWAS for the same phenotype. The significance threshold was set to P = 1×10 -8 (see
343
(55)). 
351
The phenotypes of male breed-average weight 0.303 in kg, or male breed-average height in cm,
352
were assigned to all dogs in the breed for the weight and height GWAS, respectively. We used 
373
and then randomly set 20% of the weights to missing and used a Bayesian sparse linear mixed 374 model (with a ridge regression/GBLUP fit) in GEMMA to predict these missing weights. We did 375 this randomization and prediction 50 times, and then compared the actual weights to the 376 predicted weights using a correlation coefficient.
377
378
In order to reduce phenotypic noise, we again included all four most-associated QTLs as 379 covariates in a follow-up GWAS of breed-average body weight and then, for those regions that 380 still had residual association signal, we also included the most associated SNP (in addition to the 381 four) as a covariate in the next GWAS. We continued this stepwise process of including the most-382 associated SNP in the next GWAS until there was no significant association signal in the 383 respective region remaining. The same analysis was run using the three most-associated loci 384 (HMGA2, IGF1, LCORL) and the five most-associated loci (HMGA2, IGF1, LCORL, SMAD2, 385 GHR) with comparable results (data not shown). 
623
Colors indicate amount of LD with the most significantly associated SNP, ranging from black 624 (r 2 <0.2) to red (r 2 >0.8).
625 626 S1 
635
shown is the location and P-value from the GWAS using the array genotype data.
637
S4 Table: List of Whole Genome Sequence (WGS) dog samples.
